Identifying promising practices for evaluation: the National Breast and Cervical Cancer Early Detection Program

Cancer Causes Control. 2015 May;26(5):767-74. doi: 10.1007/s10552-015-0538-z. Epub 2015 Feb 21.

Abstract

Purpose: The Centers for Disease Control and Prevention conducted a systematic screening and assessment process to identify promising practices implemented by grantees of the National Breast and Cervical Cancer Early Detection Program and its partners that were appropriate for rigorous evaluation.

Methods: The systematic screening and assessment (SSA) process was conducted from September 2010 through March 2012 and included five steps: (1) nominations of promising practices; (2) a first rating by subject matter experts; (3) field-based evaluability assessments; (4) a second rating by experts; and (5) use of results. Nominations were sought in three program areas including health education and promotion, quality assurance and quality improvement, and case management/patient navigation.

Results: A total of 98 practices were nominated of which 54 % were eligible for the first review by the experts. Fifteen practices were selected for evaluability assessment with ten forwarded for the second review by the experts. Three practices were ultimately recommended for rigorous evaluation, and one evaluation was conducted. Most nominated practices were based on evidence-based strategies rather than representing new, innovative activities. Issues were identified through the process including inconsistent implementation and lack of implementation fidelity.

Conclusion: While the SSA was successful in identifying several programs for evaluation, the process also revealed important shortcomings in program implementation. Training and technical assistance could help address these issues and support improved programming.

MeSH terms

  • Breast Neoplasms / diagnosis*
  • Centers for Disease Control and Prevention, U.S.
  • Early Detection of Cancer / methods*
  • Female
  • Health Education
  • Health Promotion
  • Humans
  • Program Evaluation*
  • Quality Assurance, Health Care*
  • Quality Improvement
  • United States
  • Uterine Cervical Neoplasms / diagnosis*